http://www.fpnotebook.com/
BreviconAka: Modicon, Ovcon
- See Also
- Preparations (Norethindrone / Ethinyl Estradiol)
- Brevicon or Modicon 0.5/35
- Ovcon 0.4/35
- Components
- Norethindrone 0.4 to 0.5 mg (see preparations above)
- Ethinyl Estradiol 35 ug
- Effect
- Relative Progestational Activity: 0.5 (low)
- Estrogenic Activity: 42 (high)
- Androgenic Activity: 0.17 (low)
- Pill associated problems
- Indications to switch to Ortho Tri-Cyclen
- Acne Vulgaris (lower androgen)
- Indications to switch to Ortho Cyclen
- Indications to switch to Ortho Novum 7/7/7
- Indications to switch to Ortho Novum 1/35
- Break-through bleed days 10-21 (more Progestin)
- Heavy Menses (more Progestin or less Estrogen)
- Dysmenorrhea or Menstrual Cramps (more Progestin)
- Indications to switch to Nordette
- Libido decreased (more androgen)
- Indications to switch to Ortho Tri-Cyclen
- References
- Cerel-Suhl (1999) Am Fam Physician 60(7):2073
- Speroff (1993) Obstet Gynecol 81:1034
- Dickey (1998) Managing Contraceptive Pill Patients
Brevicon (C0107153) | |
|---|---|
| Concepts | Steroid (T110) , Pharmacologic Substance (T121) |
| MSH | C020416 |
| English | Brevicon |
| Sources | MSH, NCI, RXNORM Derived from the NIH UMLS (Unified Medical Language System) |
Ovcon (C0722353) | |
|---|---|
| Concepts | Organic Chemical (T109) , Pharmacologic Substance (T121) , Hormone (T125) |
| English | Ovcon |
| Sources | NCI, RXNORM Derived from the NIH UMLS (Unified Medical Language System) |
Modicon (C1691769) | |
|---|---|
| Concepts | Steroid (T110) , Pharmacologic Substance (T121) , Hormone (T125) |
| MSH | C020416 |
| English | Modicon |
| Sources | MSH, NCI, RXNORM Derived from the NIH UMLS (Unified Medical Language System) |